In addition, inhibition of dipeptidyl peptidase-4, which degrades GLP-1, reduced oxidative and nitrosative stress, inflammation, memory impairment, and AβPP-Aβ deposits in an AD transgenic mouse model [314]. The gene discussed is APP; the disease is Alzheimer disease.